Ge Healthcare
Clinical trials sponsored by Ge Healthcare, explained in plain language.
-
New MRI dye aims to sharpen cancer detection
Diagnosis Not yet recruitingThis study is testing a new contrast agent called mangaciclanol for MRI scans. It aims to help doctors see and diagnose suspicious areas (lesions) in the brain or body more clearly than with the current standard agent. The trial will enroll 640 adults who are already scheduled fo…
Phase: PHASE2, PHASE3 • Sponsor: GE Healthcare • Aim: Diagnosis
Last updated Mar 30, 2026 14:31 UTC
-
New scan aims to spot hidden cancer spread in the gut
Diagnosis Not yet recruitingThis study is testing a new type of PET/CT scan to see if it can better detect cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis) in patients with certain cancers. About 175 adults with colorectal, gastric, ovarian, or pancreatic cancer who are suspec…
Phase: PHASE2, PHASE3 • Sponsor: GE Healthcare • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC
-
Hospitals seek feedback on new patient monitoring technology
Knowledge-focused Not yet recruitingThis study aims to gather feedback from both patients and hospital staff about a new portable monitoring device called Portrait Mobile. Fifty adult hospital patients will wear the device for up to three days while staying in their regular hospital unit. Afterward, participants an…
Phase: NA • Sponsor: GE Healthcare • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC
-
Doctors test new gadget to watch Patients' muscles during surgery
Knowledge-focused Not yet recruitingThis study aims to gather feedback from doctors and nurses on a new sensor and cable used to monitor muscle relaxation during surgery. The device gives electrical pulses to a nerve in the wrist and measures the muscle's response. Researchers want to know how easy the device is to…
Phase: NA • Sponsor: GE Healthcare • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:05 UTC